Bank of New York Mellon Corp - CYTOKINETICS INC ownership

CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 214 filers reported holding CYTOKINETICS INC in Q3 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of CYTOKINETICS INC
ValueSharesWeighting
Q3 2023$36,467,765
-13.6%
1,237,874
-4.3%
0.01%
-11.1%
Q2 2023$42,208,425
-6.5%
1,293,943
+0.8%
0.01%
-10.0%
Q1 2023$45,152,010
-25.5%
1,283,092
-3.0%
0.01%
-28.6%
Q4 2022$60,640,744
-8.8%
1,323,456
-3.6%
0.01%
-12.5%
Q3 2022$66,510,000
+48.9%
1,372,769
+20.7%
0.02%
+60.0%
Q2 2022$44,671,000
+44.4%
1,136,946
+35.2%
0.01%
+66.7%
Q1 2022$30,946,000
-23.0%
840,692
-4.6%
0.01%
-14.3%
Q4 2021$40,165,000
+41.8%
881,170
+11.2%
0.01%
+16.7%
Q3 2021$28,326,000
+129.9%
792,541
+27.3%
0.01%
+200.0%
Q2 2021$12,320,000
-22.9%
622,586
-9.4%
0.00%
-33.3%
Q1 2021$15,983,000
+11.9%
687,162
-0.0%
0.00%0.0%
Q4 2020$14,282,000
-6.6%
687,312
-2.7%
0.00%
-25.0%
Q3 2020$15,298,000
-1.2%
706,618
+7.6%
0.00%0.0%
Q2 2020$15,480,000
+112.6%
656,717
+6.3%
0.00%
+100.0%
Q1 2020$7,280,000
+7.2%
617,523
-3.5%
0.00%0.0%
Q4 2019$6,790,000
-6.1%
639,998
+0.7%
0.00%0.0%
Q3 2019$7,231,000
+0.1%
635,380
-1.1%
0.00%0.0%
Q2 2019$7,227,000
+50.2%
642,420
+8.0%
0.00%
+100.0%
Q1 2019$4,813,000
+28.8%
595,081
+0.6%
0.00%0.0%
Q4 2018$3,738,000
-34.7%
591,609
+1.7%
0.00%0.0%
Q3 2018$5,727,000
+25.1%
581,465
+5.4%
0.00%0.0%
Q2 2018$4,577,000
+13.7%
551,542
-1.3%
0.00%0.0%
Q1 2018$4,024,000
-8.5%
558,962
+3.5%
0.00%0.0%
Q4 2017$4,399,000
-45.1%
539,823
-2.3%
0.00%
-50.0%
Q3 2017$8,008,000
+25.6%
552,300
+4.8%
0.00%0.0%
Q2 2017$6,374,000
+231.5%
526,790
+252.0%
0.00%
+100.0%
Q1 2017$1,923,000
-3.8%
149,645
-9.0%
0.00%0.0%
Q4 2016$1,998,000
+35.7%
164,479
+2.6%
0.00%
Q3 2016$1,472,000
-5.9%
160,341
-2.8%
0.00%
Q2 2016$1,565,000
-11.1%
164,901
-33.9%
0.00%
-100.0%
Q1 2016$1,760,000
-26.8%
249,536
+8.5%
0.00%0.0%
Q4 2015$2,406,000
+140.1%
229,936
+71.4%
0.00%
Q3 2015$1,002,000
-11.9%
134,113
-20.8%
0.00%
Q2 2015$1,137,000
-3.5%
169,346
+0.1%
0.00%
Q1 2015$1,178,000
-9.0%
169,184
+4.6%
0.00%
Q4 2014$1,295,000
+118.8%
161,681
-3.8%
0.00%
Q3 2014$592,000
-63.2%
168,089
-50.1%
0.00%
Q2 2014$1,608,000
+14.4%
336,518
+127.6%
0.00%
Q1 2014$1,405,000
+62.2%
147,837
+11.1%
0.00%
Q4 2013$866,000
-56.8%
133,101
-49.7%
0.00%
Q3 2013$2,006,000264,7680.00%
Other shareholders
CYTOKINETICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
BVF INC/IL 2,106,989$14,159,0002.50%
Healthcare Value Capital, LLC 100,000$672,0000.71%
First Light Asset Management, LLC 218,792$1,470,0000.69%
IRONWOOD INVESTMENT MANAGEMENT LLC 435,202$2,925,0000.67%
TFS CAPITAL LLC 899,951$6,048,0000.59%
SPHERA FUNDS MANAGEMENT LTD. 422,250$2,838,0000.28%
ALGERT GLOBAL LLC 73,181$492,0000.27%
LANSDOWNE PARTNERS (UK) LLP 2,321,865$15,603,0000.13%
Leisure Capital Management 17,567$118,0000.12%
Rotella Capital Management, Inc. 15,778$106,0000.09%
View complete list of CYTOKINETICS INC shareholders